share_log

執行役員人事に関するお知らせ

Announcement of individual stocks regarding the appointments of Company Executives.

Santen Pharmaceutical ·  Mar 10 15:00

March 11, 2025.

Announcement of individual stocks regarding the appointments of Company Executives.

Santen Pharmaceutical Co., Ltd. (headquartered in Osaka City) announces the following regarding the personnel affairs of Company Executives.

Record

Appointment of Company Executives effective April 1, 2025.

NameNew PositionCurrent Position
Takahiro Ito*Representative Director, President, and CEO Representative Director, President, and CEO
Rie Nakajima*Company Executives
Company Executive
Chief Operating Officer Company Executives
Company Executive
Chief Operating Officer
Itsuki Kurihara*Company Executives
Company Executive
Director of Japan Business Administration and Global Commercial Strategy
Company Executive
Japan Business Administration and Global Commercial Strategy
Mariante PusahaCompany Executive
Executive Officer in charge of Europe, Middle East and Africa (EMEA) operations.
In charge of Europe, Middle East and Africa (EMEA) operations.
Sean Chuan.Company Executive
Executive Officer in charge of China operations.
In charge of China operations.
Shinichi TeramachiCompany Executive
Japan Regional Ophthalmology Division Head and Sales General Manager Company Executive
Japan Regional Ophthalmology Division Head and Sales General Manager
Tomoyuki YoshidaCompany Executive
Asia Regional General Executive
Asia Regional General
Seiko WatanabeCompany Executive
Company Executives of the Pharmaceutical business in Japan
Director of the Pharmaceutical business in Japan
Lear Hack*.Company Executive
Company Executives of the Ophthalmology Innovation Center
Director of the Ophthalmology Innovation Center
Peter Salsitig*.Company Executive
Chief Medical Officer Company Executives
Chief Medical Officer
Akaiho Bunpo*Company Executive
Chief of Staff (attached to CEO) Company Executives
Chief of Staff (attached to CEO)
Kazuhiro Koshiji*Company Executive
Chief Financial Officer Company Executives
Chief Financial Officer
Mika Masanari*Company Executive
General Counsel and Chief Compliance Officer Company Executives
General Counsel and Chief Compliance Officer
Takahiro MoritaCompany Executive
Basic Philosophy & Sustainability Global Head Company Executive.
Basic Philosophy & Sustainability Global Head.
Daisuke Nakata*.
(Newly Appointed)
Company Executive
Chief Digital & Information Officer Global Head of Digital & Information Technology.
Yoko Saiki*Company Executive
Corporate Strategy Global Head Company Executives.
Corporate Strategy Global Head.

* Corporate Management Member (CMM).

About Santen
Santen aims to contribute to the realization of people's 'Happiness with Vision' by providing valuable products and services to patients, consumers, and healthcare professionals worldwide in the ophthalmology field as a specialized company. Since its establishment, under the basic principle of 'Participating in Divine Work,' Santen has been pursuing the maintenance and enhancement of eye health for over 130 years. Currently, Santen globally conducts research and development, manufacturing, sales, and marketing activities of pharmaceuticals in the ophthalmology field, supporting the eye health of approximately 50 million people in over 60 countries and regions around the world. Our mission is to continue providing important value in the prevention, diagnosis, and treatment of eye diseases to patients and society through products and services created from ophthalmic expertise and patient perspectives that have not been provided before. To create a future where as many patients as possible can lead happy and fulfilling lives, we are committed to realizing a society where people around the world can experience happiness through 'seeing.'
For more details, please refer to our homepage.

– Contact information regarding this matter –
Santen Pharmaceutical Co., Ltd. Corporate Communication
Email: communication@santen.com

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Comment Comment · Views 274

Recommended

Write a comment

Statement

This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.